A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are well established as effective treatments for patients with type 2 diabetes. GLP-1 RAs augment insulin secretion and suppress glucagon release via the stimulation of GLP-1 receptors. Although all GLP-1 RAs share the same underlying mechanism o...

Descripción completa

Detalles Bibliográficos
Autores principales: Romera, Irene, Cebrián-Cuenca, Ana, Álvarez-Guisasola, Fernando, Gomez-Peralta, Fernando, Reviriego, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349277/
https://www.ncbi.nlm.nih.gov/pubmed/30506340
http://dx.doi.org/10.1007/s13300-018-0535-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349277/
https://www.ncbi.nlm.nih.gov/pubmed/30506340
http://dx.doi.org/10.1007/s13300-018-0535-9

Ejemplares similares